These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

58 related items for PubMed ID: 4129591

  • 1. Dopa and 5-S-cysteinyldopa in the urine in healthy humans.
    Agrup G, Falck B, Kennedy BM, Rorsman H, Rosengren AM, Rosengren E.
    Acta Derm Venereol; 1973; 53(6):453-4. PubMed ID: 4129591
    [No Abstract] [Full Text] [Related]

  • 2. Excretion of 5-S-cysteinyldopa in the urine of healthy subjects.
    Agrup G, Falck B, Fyge K, Rorsman H, Rosengren AM, Rosengren E.
    Acta Derm Venereol; 1975; 55(1):7-9. PubMed ID: 46677
    [Abstract] [Full Text] [Related]

  • 3. 5-S-cysteinyldopa in the plasma of melanoma patients and the renal clearance of this amino acid.
    Agrup G, Andersson T, Falck B, Persson K, Rorsman H, Rosengren AM, Rosengren E.
    Acta Derm Venereol; 1975; 55(1):5-6. PubMed ID: 46673
    [Abstract] [Full Text] [Related]

  • 4. Quantitative determination of 5-S-cysteinyldopa, dopa and dopamine in the urine by means of high-performance liquid chromatography. A comparison with data obtained by means of fluorometry.
    Morishima T, Saito M, Hanawa S.
    J Dermatol; 1981 Aug; 8(4):301-4. PubMed ID: 6795251
    [No Abstract] [Full Text] [Related]

  • 5. Protein-bound dopa and 5-S-cysteinyldopa in non-melanogenic tissues.
    Ito S, Jimbow K, Kato T, Kiyota M, Fujita K.
    Acta Derm Venereol; 1983 Aug; 63(6):463-7. PubMed ID: 6198833
    [Abstract] [Full Text] [Related]

  • 6. Fluorometry of a DOPA peptide and its thioether.
    Rorsman H, Rosengren AM, Rosengren E.
    Acta Derm Venereol; 1971 Aug; 51(3):179-82. PubMed ID: 4103734
    [No Abstract] [Full Text] [Related]

  • 7. Diastereomers of 5-S-cysteinyldopa.
    Agrup G, Edholm LE, Rorsman H, Rosengren E.
    Acta Derm Venereol; 1983 Aug; 63(1):59-61. PubMed ID: 6191491
    [Abstract] [Full Text] [Related]

  • 8. Urinary 5-S-cysteinyldopa in Parkinsonism after DOPA and carbidopa.
    Stewart RM, Miller S, Gunder M.
    Acta Derm Venereol; 1983 Aug; 63(2):97-101. PubMed ID: 6189350
    [Abstract] [Full Text] [Related]

  • 9. 5-S-cysteinyldopa, dopa, and dopamine in the kidney and some other tissues.
    Agrup G, Hansson C, Rorsman H, Rosengren E.
    Acta Derm Venereol; 1980 Aug; 60(1):63-4. PubMed ID: 6153836
    [Abstract] [Full Text] [Related]

  • 10. Determination of 5-S-cysteinyldopa in melanomas with a fluorimetric method.
    Rorsman H, Rosengren AM, Rosengren E.
    Yale J Biol Med; 1973 Dec; 46(5):516-22. PubMed ID: 4779132
    [No Abstract] [Full Text] [Related]

  • 11. [Urinary 5-S-cysteinyldopa levels in patients with malignant melanoma. Preliminary results].
    Césarini JP, Meunier M.
    Rev Prat; 1975 Nov; 25(51):4037-9. PubMed ID: 1209143
    [No Abstract] [Full Text] [Related]

  • 12. 5-S-Cysteinyldopa and dopa in serum during treatment with 8-methoxypsoralen and UVA light.
    Hansson C, Rorsman H, Rosengren E, Tegner E.
    Acta Derm Venereol; 1981 Nov; 61(3):251-5. PubMed ID: 6167110
    [Abstract] [Full Text] [Related]

  • 13. Seasonal variation in urinary excretion of 5-S-cysteinyldopa in healthy Japanese.
    Ito S, Kato T, Fujita K.
    Acta Derm Venereol; 1987 Nov; 67(2):163-5. PubMed ID: 2438883
    [Abstract] [Full Text] [Related]

  • 14. S-(beta-carboxy-n-propyl)-L-cysteine and S-(beta-carboxyethyl)-L-cysteine in urine.
    Ohmori S, Shimomura T, Azumi T, Mizuhara S.
    Biochem Z; 1965 Nov 05; 343(1):9-15. PubMed ID: 5874986
    [No Abstract] [Full Text] [Related]

  • 15. Selective toxicity of 5-S-cysteinyldopa, a melanin precursor, to tumor cells in vitro and in vivo.
    Fujita K, Ito S, Inoue S, Yamamoto Y, Takeuchi J, Shamoto M, Nagatsu T.
    Cancer Res; 1980 Jul 05; 40(7):2543-6. PubMed ID: 6771000
    [Abstract] [Full Text] [Related]

  • 16. 5-OH-dopa, product of and substrate for tyrosinase.
    Agrup G, Rorsman H, Rosengren E.
    Acta Derm Venereol; 1982 Jul 05; 62(5):371-76. PubMed ID: 6183884
    [Abstract] [Full Text] [Related]

  • 17. 5-S-cysteinyldopa as a substrate for tyrosinase.
    Hansson C, Rorsman H, Rosengren E.
    Acta Derm Venereol; 1980 Jul 05; 60(5):399-402. PubMed ID: 6162310
    [Abstract] [Full Text] [Related]

  • 18. Precursors of melanin in the blood and urine in malignant melanoma.
    Hinterberger H, Freedman A, Bartholomew RJ.
    Clin Chim Acta; 1972 Jul 05; 39(2):395-400. PubMed ID: 5043774
    [No Abstract] [Full Text] [Related]

  • 19. Urine excretion of 5-S-cysteinyldopa and serum sialic acid as tumor markers in human melanomas.
    Marnot D, Decaux F, Berthelot P, Kalis B, Jardillier JC, Warren L.
    Cancer Detect Prev; 1983 Jul 05; 6(1-2):303-10. PubMed ID: 6411338
    [Abstract] [Full Text] [Related]

  • 20. A sensitive method for determination of 5-S-cysteinyldopa.
    Rorsman H, Rosengren AM, Rosengren E.
    Acta Derm Venereol; 1973 Jul 05; 53(4):248-50. PubMed ID: 4127449
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.